The Indian Practitioner

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Newer and Future Insulins


Affiliations
1 Hospital CIMA Hermosillo. Paseo Rio San Miguel No. 35. 2do piso.Col. Proyecto Rio Sonora. Hermosillo, Sonora, Mexico
2 Investigacion Medica Sonora, S.C., Hermosillo, Sonora, Mexico
     

   Subscribe/Renew Journal


The management of Diabetes was revolutionised by discovery of insulin. However the insulin delivery as well action profile of initial insulins were far from physiological. The initial insulins were replaced by recombinant insulins and later by insulin analogues.

Further refinements in insulin therapy are aimed at making these analogues more physiological, minimise risk of hypoglycaemia, making delivery timing more flexible, reduce/avoid need for injections etc.

The review summarises the recently available insulin analogues as well as few advances in the pipeline.


Subscription Login to verify subscription
User
Notifications
Font Size


Abstract Views: 228

PDF Views: 1




  • Newer and Future Insulins

Abstract Views: 228  |  PDF Views: 1

Authors

Diego Espinoza-Peralta
Hospital CIMA Hermosillo. Paseo Rio San Miguel No. 35. 2do piso.Col. Proyecto Rio Sonora. Hermosillo, Sonora, Mexico
Jorge Rogel-Manzanares
Investigacion Medica Sonora, S.C., Hermosillo, Sonora, Mexico

Abstract


The management of Diabetes was revolutionised by discovery of insulin. However the insulin delivery as well action profile of initial insulins were far from physiological. The initial insulins were replaced by recombinant insulins and later by insulin analogues.

Further refinements in insulin therapy are aimed at making these analogues more physiological, minimise risk of hypoglycaemia, making delivery timing more flexible, reduce/avoid need for injections etc.

The review summarises the recently available insulin analogues as well as few advances in the pipeline.